Skip to main content
. 2020 Mar 11;6(3):359–381. doi: 10.1002/vms3.239

Table 1.

Summary of zoonotic bacterial diseases of camels reported in Iran; 1890–2018

A. Bacterial diseases
Disease Year Location Techniques No. positive/ No. tested (%) Ref
Leptospirosis 1959 Various area of Iran 1/5 (20%) (Rafyi & Maghami, 1959)
1996 South Khorasan (Tabas) Serological test 1/14 (7%) (Hadian, 1996)
2008–2011 Yazd Microscopic agglutination test 22/8% No Numeral data (Sazmand, 2012)
2010–2011 Various area of Iran Bacterial culture, multiplex PCR 7/35 (20%), 8/35 (22.85%) (Safarpoor Dehkordi et al., 2012; Safarpoor Dehkordi & Taghizadeh 2012)
2012 Isfahan PCR 19/130 (14.61%) (Doosti et al., 2012)
2012 Isfahan Bacterial culture, Multiplex PCR 7/49 (14.29%), 8/49 (6.33%) (Dehkordi et al., 2012; Dehkordi and Taghizadeh 2012)
2013 Yazd Microscopic agglutination test 30/128 (32.4%) (Hajikolaei et al., 2013)
2013 Qom Microscopic agglutination test 51/183 (27.87%) (Talebi, 2007)
2014 Ardabil Microscopic agglutination test 12/60 (20%) (Afkhamnia, Avagyan, Khaki, Bidhendi, & Mostafaey, 2014)
Q fever 1959 ELISA 2/12 (16.66%) (Moghaddas, 2012 2012)
2011 Isfahan PCR 14/130 (10.76%) (Doosti et al., 2014)
2015 North, South and Razavi Khorasan ELISA 48/168 (28.7%) (Janati Pirouz et al., 2015)
2016 Khorasan ( North, South, Razavi) PCR 4/167 (2.4%) (Pirouz, Mohammadi, Mehrzad, & Aziz zadeh, 2016)
Brucellosis 1987 Fars Tube agglutination, RBPT 2/238 (0.84%) (Motamedi, 1987)
1986–1987 Qazvin RBPT, SAT, 2ME, CFT 77/935 (8%) (Zowghi & Ebadi, 1991)
1994 Isfahan (Najaf Abad) RBPT 5/100 (0.05%) (Miranzade, 1994)
1999 Bushehr RBPT, SAT, 2ME, CFT 5/258 (1.93%) (Khadjeh, Zowghi, & Zarif‐fard, 1999)
2005 Isfahan (Najaf Abad) RBPT, Wright, 2ME 11/384 (2.84%) (Pourjafar et al. 2005)
2007 Hormozgan RBPT 3/103 (2.91%) (Garib, 2011)
2011 Sistan and Baluchestan RBPT, SAT, 2ME 17/500 (3.4%) (Sargaz, 2011)
2008–2011 Yazd RBPT 149/395 (37.83%) (Sazmand, Rasooli, et al., 2012)
2012 Isfahan (Najaf Abad) (RBPT, mRB, Wright, 2ME), PCR, Culture 39/310 (12.58%) mRB; 27/310 (8.71%) RBPT; 7/310 (2.26%) Wright; 6/310 (1.94%) 2ME; 18.6/310 (6%) PCR (Ghorbani et al., 2013)

2012

Isfahan Multiplex PCR, Culture 4/35 (11.42%) aborted fetus (Dehkordi et al., 2012; Dehkordi and Taghizadeh 2012)
2012 Various part of Iran Conventional PCR, real‐time PCR assays 201/618 (32.52%) C‐PCR, 143/201 (71%), RT‐PCR (Dehkordi et al., 2012; Dehkordi and Taghizadeh 2012)
2014 Isfahan PCR, blood sample, lymph node 14/123 (11.38%) blood sample; 16/123 (13.01%) lymph node samples (Khamesipour, Doosti, Mobarakeh, & Komba, 2014; Khamesipour, Rahimi, Shakerian, Doosti, & Momtaz, 2014)
2015 Isfahan (Najaf Abad) RBPT, Tube agglutination, 2ME, PCR 18/150 (12%) RBPT; 12/150 (8%) TG, 9/150 (6%) 2ME; 3/150 (1.3%) PCR (Mahzunieh & Salami, 2015)
Campylobacteriosis 2006–2006 Fars, Bushehr Culture PreT‐KB method 3/145 (2%) (Baserisalehi et al., 2007)
2007–2008 Isfahan (Najaf‐Abad) Bacteriological examination 5/94 (2%) (Rahimi, Momtaz, & Nozarpour, 2010)
2008–2009 Isfahan, Yazd Microbiological analysis 1/107 (0.9%) (Rahimi, Momtaz, et al., 2010)
2010 Chaharmahal & Bakhtiari, Khuzestan PCR 3/130 (2.3%) (Rahimi et al., 2013)
Plague 1960 Iran (McGrane & Higgins, 1985)
1974 Iran (Fedorov, 1960)
Tuberculosis Khorasan Razavi PCR 4/100 (4%) (Hashemi et al., 2002)
2009–2010 Khorasan Razavi (Mashhad) PCR 17/102 (16.66%) (Soleymani Babadi et al., 2012)
Pasteurellosis 2010 Fars (Larestan) Morphological, cultural, biomedical characterization 53/100 (53%) (Esmaeili et al., 2010)
2014 Iran DNA extraction, PCR assay 104/971 (10.7%) (Chitgar et al., 2014)
2014–2015 Fars (Larestan) Morphological, cultural, biomedical characterization 4/5 (80%) dead camels, 31/48 (64.58%) clinical camels, 8/109 (7.34%) healthy camels (Tahamtan et al., 2017)
Salmonellosis 1992 North East of Iran Bacteriological examination Serological test 14/113 (12.39%), 38/102 (37.25) (Moghaddas, 2012 2012)
1994 Isfahan (Najaf Abad) Agar gel immunodiffusion test (AGIT) 1/59 (1.69%) (Miranzade, 1994)
2007–2008 Isfahan (Najaf Abad) Bacteriological examination Case report (Rahimi et al., 2012)
2010 Isfahan (Najaf Abad) Agar gel immunodiffusion test 3/384 (0.78%) (Pourjafar, Mahzounieh, Zahraei Salehi, & Habibollahi Khorasgani, 2010)
2010 Tehran Microbiology test, Histopathology, Gross Pathology, Clinical Pathology 1/94 (1.1%) (Nour‐Mohammadzadeh et al., 2010)
2010–2011 West Azerbaijan (Urmia region) Bacteriological examination, PCR 4/100 (4%) (Ahmadi, 2012)
2011–2012 Fars and Khuzestan Bacteriological examination, PCR 1/50 (2.0%) (Rahimi et al., 2012)
2012 Razavi Khorasan Microbiology 10% (Gholami et al., 2014)
2012 Various parts of Iran Microbiology 84/196 (43%) (Sepehr, 2012)
2013 Kerman PCR 8% (Zavarshani, Kownani, Estabraghi, & Yarahmadi, 2015)
2015 Golestan Quantitative agglutination test 9/9 (100%) (Rabbani Khorasani, Eatemadifar, Azadbakht, Emami, & Khormali, 2015)
2016 Razavi Khorasan (Mashhad) Microbiology 2/10 (20%) (Mohammady & Najafi Mosleh, 2017)
Listeriosis 2007–2008 Isfahan Najaf Abad Bacteriological test 9/94 (9.6%) (Rahimi, Momtaz, et al., 2010)
2011 Sistan and Baluchestan (Sistan) Bacteriological examination 3/80 (3.75%) (Safdari & Jahantigh, 2014)
2011 Various parts of Iran Culture, PCR, Technique Real‐Time PCR, 6/101 (5.94%) Milk; 3/100 (3%) Faeces; 10/79 (13.92%) Vaginal Swab; 8/95 (9.47%) Urine (Dehkordi, Barati, Momtaz, Ahari, & Dehkordi, 2013; Dehkordi, Haghighi Borujeni, Rahimi, & Abdizadeh, 2013)
2011–2012 Tehran Microbiological tests 6/24 (25%) Frozen meat, 12/24 (50%) Fresh meat (Mashak et al., 2015)